Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 28 out of 100. Down syndrome and Alzheimer's

Topic: Risk, prevention and care in population studies

A fifteen-year follow up of the linguistic and cognitive profile of a woman, named Françoise, with standard trisomy 21. She had been studied in considerable detail between 1987 and 1991 by Rondal (1995) and found to have exceptionally good language abilities in advance of regular cognitive abilities for a person with Down syndrome. Françoise's psychological functioning has been deteriorating relatively rapidly over the last two years. A severe deterioration of her previously excellent receptive language abilities is documented in the present study. Productively, her on-line word finding is becoming problematic, mean length of utterance has halved compared with 15 years ago, and production of compound sentences is reduced. However, basic phonological and morphosyntactic skills are preserved. Françoise's changing profile during the latter years seems to mirror that documented in the first stages of Alzheimer disease in ageing adults in the general population.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Rondal, J. A., Elbouz, M., Ylieff, M., & Docquier, L. (2003). Françoise, a fifteen-year follow up. Down's syndrome, research and practice : the journal of the Sarah Duffen Centre. https://doi.org/10.3104/case-studies.135

Vancouver

Rondal JA, Elbouz M, Ylieff M, Docquier L. Françoise, a fifteen-year follow up. Down's syndrome, research and practice : the journal of the Sarah Duffen Centre. 2003. doi:10.3104/case-studies.135. PMID: 14502836.

BibTeX

@article{rondal2003-14502836,
  author  = {Rondal, J. A. and Elbouz, M. and Ylieff, M. and Docquier, L.},
  title   = {{Françoise, a fifteen-year follow up}},
  journal = {Down's syndrome, research and practice : the journal of the Sarah Duffen Centre},
  year    = {2003},
  doi     = {10.3104/case-studies.135},
  pmid    = {14502836},
  url     = {https://doi.org/10.3104/case-studies.135}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This fifteen-year follow-up of one woman with trisomy 21 documents declining language abilities that resemble early Alzheimer's disease. As a single-person descriptive report, it offers no information on treating, curing or preventing Alzheimer's disease.

Study details

How this study scored 28/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 0 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 1 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 2 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record left out, no data; Institution's track record 1 of 3; Multi-centre collaboration 0 of 3; Indexed in PubMed 2 of 2; Free to read 0 of 2. 27 of the 96 points it could be judged on, which is 28 of 100. Total 28 of 100.27 of the 96 points we could judge = 28 of 100

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported and randomised / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 27 of the 96 points we could judge it on, which is 28 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Down's syndrome, research and practice : the journal of the Sarah Duffen Centre)
Journal's citation record 0 / 4 Down Syndrome Research and Practice: journal h-index 50 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 1 / 5 2003 — older than 20 years, still counted
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (pubmed indexes it as a clinical or observational study)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 2 / 7 Cited 8 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.3 citations a year over 25 year(s) since 2003
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record — / 4 OpenAlex's profile for last-listed author Laurence Docquier holds only 7 work(s), too few to judge a track record — left out of this score
Institution's track record 1 / 3 University of Liège: institution h-index 901 (OpenAlex)
Multi-centre collaboration 0 / 3 OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 14502836)
Free to read 0 / 2 Behind a paywall — scores zero
Points 27 / 96 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 27 of the 96 points we could judge it on is 28 out of 100.
Total 28 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Down syndrome and Alzheimer's

Also in Down syndrome and Alzheimer's

12 studies in the library are filed under Down syndrome and Alzheimer's with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Down syndrome and Alzheimer's hub.

Similar studies

More on Down syndrome and Alzheimer's

See all studies in Down syndrome and Alzheimer's →